NDC 0597-0295 – Synjardy XR

Empagliflozin 25 mg/1; Metformin Hydrochloride 1000 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug 2 recalls

Product NDC0597-0295

Product details

Brand name
Synjardy XR
Generic name
Empagliflozin, metformin hydrochloride
Labeler
Boehringer Ingelheim Pharmaceuticals, Inc.
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
NDA · NDA208658
Marketed since
December 10, 2016
Listing expires
December 31, 2027
Pharmacologic class
Biguanide; Sodium-Glucose Cotransporter 2 Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Synjardy →

Package NDC codes (3)

Package NDCDescriptionSince
0597-0295-61 sample1 BOTTLE in 1 CARTON (0597-0295-61) / 7 TABLET, EXTENDED RELEASE in 1 BOTTLEDec 10, 2016
0597-0295-7890 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0295-78)Dec 10, 2016
0597-0295-8830 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0295-88)Dec 10, 2016

Recalls mentioning this NDC

Other Synjardy products